Security record · archived quarter
SNY
Sanofi · Healthcare · Drug Manufacturers - General
13Tracked holders
n/aΔ holders
103.00MShares held
$5.00BReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 517.20K | $21.14M | n/a | n/a |
| Q2 2026 | 111 | +6 | 144.61M | $6.22B | +8 | −2 |
| Q1 2026 | 107 | -7 | 161.36M | $7.80B | +3 | −10 |
| Q4 2025 | 113 | 0 | 171.90M | $8.37B | n/a | n/a |
| Q3 2025 | 17 | 0 | 119.31M | $5.63B | +1 | −1 |
| Q2 2025 | 14 | -1 | 113.96M | $5.51B | n/a | −1 |
| Q1 2025 | 13 | -1 | 114.44M | $6.35B | +1 | −2 |
| Q4 2024 | 14 | 0 | 106.76M | $5.15B | n/a | n/a |
| Q3 2024 | 13 | 0 | 105.96M | $6.11B | +1 | −1 |
| Q2 2024 | 13 | n/a | 103.00M | $5.00B | n/a | n/a |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 77.11M | n/a | $3.74B | 2.2% | n/c | 1 | SEC ↗ |
| 2 | Fisher Asset Management ✦ | 13.60M | n/a | $659.80M | 0.3% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 4.78M | n/a | $232.05M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 4 | Millennium Management ✦ | 3.15M | n/a | $153.01M | 0.1% | n/c | 1 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 1.86M | n/a | $90.33M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 6 | PRIMECAP Management ✦ | 1.12M | n/a | $54.21M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Viking Global Investors ✦ | 326.29K | n/a | $15.83M | 0.1% | n/c | 1 | SEC ↗ |
| 8 | Arrowstreet Capital ✦ | 316.41K | n/a | $15.35M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Geode Capital Management ✦ (passive) | 237.96K | n/a | $11.55M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Point72 Asset Management ✦ | 211.49K | n/a | $10.26M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Soros Fund Management ✦ | 150.00K | n/a | $7.28M | 0.2% | n/c | 1 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 125.44K | n/a | $6.09M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 13 | AQR Capital Management ✦ | 7.09K | n/a | $344,000 | 0.0% | n/c | 1 | SEC ↗ ×2 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 734 holders, 204.41M shares, $9.56B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API